Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Precision Medicine

President Submits FY16 Budget; Proposes Funding for Obamacare, ‘Precision Medicine’ Research, Ebola

Washington, DC, February 3, 2015 The Washington Post reports that President Obama is seeking $83.8 billion in discretionary funding for the Department of Health and Human Services (HHS) for a broad range of efforts, from ongoing support of the health-care law to speeding development of medical innovations to safeguarding the nation’s food supply.

The budget includes $4.9 billion for the Food and Drug Administration (FDA) — a nine percent increase over 2015 funding levels.

The FDA would receive money as part of the president’s multi-agency efforts to invest in “precision medicine” and to help reduce the number of infections caused by the growing problem of antibiotic-resistant bacteria. Continue reading

President Unveils ‘Precision Medicine’ Initiative; Seeks to Revolutionize Disease Treatment

Washington, DC, February 1, 2015 ― Building on President Obama’s announcement in his State of the Union Address, the Administration on Friday unveiled details about the Precision Medicine Initiative, a bold new research effort to revolutionize how we improve health and treat disease.

Launched with a $215 million investment in the President’s 2016 Budget, the Precision Medicine Initiative will pioneer a new model of patient-powered research that promises to accelerate biomedical discoveries and provide clinicians with new tools, knowledge, and therapies to select which treatments will work best for which patients. Continue reading

NYT: President to Request Research Funding for Treatments Tailored to Patients’ DNA

Washington, DC, January 26, 2015 The New York Times’ Robert Pear reports that President Obama will seek hundreds of millions of dollars for a new initiative to develop medical treatments tailored to genetic and other characteristics of individual patients, administration officials say.

The proposal, mentioned briefly in his State of the Union address, will be described in greater detail in his budget in the coming weeks.  The effort is likely to receive support from members of both parties, lawmakers said.

In his address, President Obama called it “precision medicine,” but the terms “personalized medicine” and “individualized medicine” are also widely used to describe the evolving field in which, for example, a doctor prescribes a medication that targets a specific mutation in a patient’s genes. Continue reading